PPV without ILM peeling favourable for ODP

Article

Pars plana vitrectomy, endolaser photocoagulation and C3F8 gas tamponade without internal limiting membrane (ILM) peeling have been found to be potentially favourable in the treatment of optic disc pit (ODP) maculopathy, according to data published in Eye.

Pars plana vitrectomy, endolaser photocoagulation and C3F8 gas tamponade without internal limiting membrane (ILM) peeling have been found to be potentially favourable in the treatment of optic disc pit (ODP) maculopathy, according to data published in Eye.

Dr R. Avci et al. (Retina Eye Hospital, Bursa, Turkey) examined 13 eyes from 12 patients undergoing surgery to treat serous macular detatchment and/or macular retinoschisis secondary to congenital ODP. All patients included in the study were treated with PPV, posterior hyaloid removal, endolaser photocoagulation on the temporal margin of the optic disc and 12% C3F8 gas tamponade.

The team used optical coherence tomography (OCT) to analyse the anatomic success and functional outcome of surgery and they measured the patients’ best-corrected visual acuity (BCVA) as well. The majority of the study group experienced an improvement in BCVA of 2 lines or more and 12 eyes experienced complete reabsorption or subretinal and intraretinal fluid.

These results indicated that PPV, C3F8 gas tamponade and endolaser to the optic disc margin without ILM peeling could be a beneficial surgical option for patients suffering with ODP maculopathy and earlier surgical intervention leads to better visual improvements.

For further information please view the abstract here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.